Table 3. Patient enrollment status of Seoul National University Prospectively Enrolled Registry for Genitourinary Cancer (SUPER-GUC) at the end of December, 2018.
| Cohort | First enrollment date | Number of patients |
|---|---|---|
| SUPER-PC | 929 | |
| SUPER-PC-RP | March 6, 2016 | 765 |
| SUPER-PC-AS | December 23, 2016 | 56 |
| SUPER-PC-RT | May 20, 2016 | 39 |
| SUPER-PC-HSPC | October 18, 2016 | 56 |
| SUPER-PC-CRPC | April 3, 2017 | |
| SUPER-RCC | 796 | |
| SUPER-RCC-Nx | March 10, 2016 | 762 |
| SUPER-RCC-mRCC | June 2, 2016 | 34 |
| SUPER-UC | 1,221 | |
| SUPER-UC-TURB | March 21, 2016 | 859 |
| SUPER-UC-Cx | March 21, 2016 | 170 |
| SUPER-UC-UTUC | March 7, 2016 | 163 |
| SUPER-UC-mUC | March 28, 2016 | 29 |
SUPER, Seoul National University Prospectively Enrolled Registry; PC, prostate cancer; RP, radical prostatectomy; AS, active surveillance; RT, radiation therapy; HSPC, hormone-sensitive prostate cancer; CRPC, castration-resistant prostate cancer; RCC, renal cell carcinoma; Nx, nephrectomy; mRCC, metastatic renal cell carcinoma; UC, urothelial cancer; TURB, transurethral resection of bladder tumor; Cx, cystectomy; UTUC, upper urinary tract urothelial cancer; mUC, metastatic urothelial cancer.